Y mAbs Therapeutics (YMAB) Insider Trading
- $20,618,215.91
- $58,019,351.58
- March 5, 2024
- Thomas Gad
Trader Name | Date | Title | Amount | Price | Type | Total Value |
---|---|---|---|---|---|---|
March 5, 2024 | SVP | 1,711 | $16.53 | Sell | $28,282.83 | |
Dec. 15, 2023 | Insider | 50,000 | $6.61 | Sell | $330,500.00 | |
Dec. 13, 2023 | Insider | 50,000 | $6.58 | Sell | $329,000.00 | |
Dec. 11, 2023 | Director | 102,863 | $7.01 | Buy | $721,069.63 | |
Dec. 7, 2023 | Director | 6,183 | $6.50 | Buy | $40,189.50 | |
Nov. 29, 2023 | Director | 51,837 | $5.97 | Buy | $309,466.89 | |
Nov. 27, 2023 | Director | 62,516 | $5.49 | Buy | $343,212.84 | |
Nov. 20, 2023 | Insider | 75,000 | $5.30 | Sell | $397,500.00 | |
May 15, 2023 | Director | 101,740 | $9.65 | Buy | $981,791.00 | |
Nov. 15, 2022 | CMO | 1,195 | $4.92 | Buy | $5,879.40 | |
Feb. 22, 2022 | CFO | 4,000 | $7.85 | Sell | $31,400.00 | |
Feb. 9, 2022 | Insider | 64,276 | $6.96 | Sell | $447,360.96 | |
Feb. 7, 2022 | Insider | 91,031 | $7.59 | Sell | $690,925.29 | |
Feb. 4, 2022 | CFO | 4,000 | $7.97 | Sell | $31,880.00 | |
Feb. 3, 2022 | Insider | 35,060 | $7.90 | Sell | $276,974.00 | |
Feb. 1, 2022 | Insider | 8,000 | $10.15 | Sell | $81,200.00 | |
Jan. 24, 2022 | CFO | 4,000 | $9.84 | Sell | $39,360.00 | |
Jan. 24, 2022 | Insider | 88,055 | $10.63 | Sell | $936,024.65 | |
Jan. 20, 2022 | Insider | 112,767 | $11.33 | Sell | $1,277,650.11 | |
Jan. 18, 2022 | Insider | 8,000 | $11.54 | Sell | $92,320.00 | |
Jan. 4, 2022 | CFO | 4,000 | $17.12 | Sell | $68,480.00 | |
Dec. 22, 2021 | CFO | 4,000 | $16.36 | Sell | $65,440.00 | |
Dec. 6, 2021 | Insider | 44,000 | $16.48 | Sell | $725,120.00 | |
Dec. 6, 2021 | CFO | 4,000 | $16.35 | Sell | $65,400.00 | |
Nov. 29, 2021 | Insider | 22,437 | $17.16 | Sell | $385,018.92 | |
Nov. 23, 2021 | Insider | 50,000 | $17.06 | Sell | $853,000.00 | |
Nov. 22, 2021 | CFO | 4,000 | $18.09 | Sell | $72,360.00 | |
Nov. 16, 2021 | Insider | 4,000 | $19.33 | Sell | $77,320.00 | |
Oct. 29, 2021 | Insider | 4,000 | $24.82 | Sell | $99,280.00 | |
Oct. 22, 2021 | CFO | 4,000 | $25.94 | Sell | $103,760.00 | |
Oct. 15, 2021 | Insider | 4,000 | $27.20 | Sell | $108,800.00 | |
Oct. 4, 2021 | CFO | 4,000 | $28.78 | Sell | $115,120.00 | |
Sept. 30, 2021 | Insider | 4,000 | $28.26 | Sell | $113,040.00 | |
Sept. 22, 2021 | CFO | 4,000 | $30.82 | Sell | $123,280.00 | |
Sept. 15, 2021 | Insider | 4,000 | $33.64 | Sell | $134,560.00 | |
Sept. 7, 2021 | CFO | 4,000 | $32.03 | Sell | $128,120.00 | |
Sept. 2, 2021 | Insider | 50,000 | $33.18 | Sell | $1,659,000.00 | |
Aug. 23, 2021 | CFO | 4,000 | $28.60 | Sell | $114,400.00 | |
Aug. 16, 2021 | Insider | 26,111 | $29.30 | Sell | $765,052.30 | |
Aug. 13, 2021 | Insider | 1,110 | $31.01 | Sell | $34,421.10 | |
Aug. 12, 2021 | CMO | 1,374 | $29.95 | Buy | $41,151.30 | |
Aug. 4, 2021 | CFO | 4,000 | $33.72 | Sell | $134,880.00 | |
July 22, 2021 | CFO | 4,000 | $34.50 | Sell | $138,000.00 | |
July 22, 2021 | CFO | 4,000 | $34.50 | Sell | $138,000.00 | |
July 20, 2021 | Insider | 4,000 | $32.47 | Sell | $129,880.00 | |
July 6, 2021 | CFO | 4,000 | $34.15 | Sell | $136,600.00 | |
June 22, 2021 | CFO | 4,000 | $36.17 | Sell | $144,680.00 | |
June 14, 2021 | Insider | 4,000 | $35.80 | Sell | $143,200.00 | |
June 9, 2021 | Director | 116,700 | $36.19 | Sell | $4,223,373.00 | |
June 7, 2021 | Major Shareholder | 72,400 | $34.15 | Sell | $2,472,460.00 |
Insiders are both buying and selling Y mAbs Therapeutics stock.
The insider traders at Y mAbs Therapeutics are: Thomas Gad, Bo Kruse, Johan Wedell-Wedellsborg, Biotech Aps Wg, Vignesh Rajah, Pedro Claus Juan Moller-San, James Healy, Mahiuddin Ahmed, David N Gill, Moller San Pedro Claus Juan, and Ashu Tyagi
The most active insider trader at Y mAbs Therapeutics is Thomas Gad with 69 trades.
Thomas Gad has sold the most Y mAbs Therapeutics stock with a total value of $30,617,722.26.
Ashu Tyagi has bought the most Y mAbs Therapeutics stock with a total value of $13,765,568.00.
The most recent insider trade for Y mAbs Therapeutics was on March 5, 2024.
The single biggest insider buy for Y mAbs Therapeutics was from James Healy with a total value of $8,000,000.00 on Sept. 21, 2018.
The single biggest insider sell for Y mAbs Therapeutics was from Thomas Gad with a total value of $6,472,500.00 on April 11, 2019.